ESR1 rs10048146: What Your Genotype Means
The rs10048146 variant is a single nucleotide polymorphism located within the ESR1 gene, which encodes the estrogen receptor alpha protein. Research has explored its potential associations with the timing of menarche and variations in bone density responses to sex hormones.
What each genotype means
Typical bone density profile
This genotype represents the non-risk version of this variant in the context of bone mineral density studies. Research suggests that individuals with this genotype do not carry the specific allele associated with decreased hip bone mineral density in large-scale meta-analyses. This association is based on statistical population trends and does not predict individual bone health or fracture risk.
This is the most common genotype in many populations, though frequencies vary significantly by ancestry.
Intermediate bone density association
Carrying one copy of the G allele may be associated with a slight statistical decrease in hip bone mineral density compared to the A/A genotype. Because this is a complex trait influenced by many genetic and environmental factors, this genotype alone does not determine your bone health. You should discuss any concerns regarding bone density or screening with your healthcare provider.
This heterozygous genotype is found in a significant portion of the population, reflecting the common nature of this variant.
Potential lower bone density
The G allele has been identified in genome-wide association studies as a risk allele linked to a modest decrease in hip bone mineral density. This finding is based on population-level data and does not mean you will experience low bone density or osteoporosis. Bone health is influenced by many factors, and you should consult your physician for personalized guidance on bone health maintenance.
This genotype is less common than the A/A or A/G combinations in many populations, with the G allele frequency reported at approximately 0.19 to 0.42 depending on the specific ancestral group.
Understanding the rs10048146 Variant
The rs10048146 variant is a specific change in the DNA sequence located within the ESR1 gene on chromosome 6. In genomics, a single nucleotide polymorphism (SNP) like rs10048146 represents a position where one of the four chemical bases—adenine, thymine, cytosine, or guanine—differs between individuals. This particular variant is situated in a region of the gene that may influence how the ESR1 gene is regulated or expressed. Because it is located in a non-coding or regulatory region, it does not change the structure of the protein itself, but rather may affect the amount or timing of the protein's production in specific tissues. Scientists study these variants to understand how subtle differences in our genetic code contribute to the natural diversity observed in human physiological traits.
The Role of the ESR1 Gene
The ESR1 gene provides instructions for making a protein called estrogen receptor alpha. This receptor is a critical component of the endocrine system, acting as a sensor that allows cells to respond to estrogen, a primary sex hormone. Once estrogen binds to this receptor, the complex moves into the cell nucleus to turn specific genes on or off. This process is essential for the development and maintenance of various tissues, including the reproductive system, bone density, and cardiovascular health. Because estrogen signaling is so widespread, variations in the ESR1 gene can have broad physiological impacts. Understanding how this gene functions helps researchers investigate why individuals may have different biological responses to hormonal changes throughout their lives, particularly regarding bone health and reproductive development.
Research Associations and Evidence Strength
Current research into rs10048146 has primarily focused on its potential links to reproductive traits, such as the age of menarche, and its influence on bone mineral density. While some studies have identified statistical correlations between this variant and these traits, the evidence strength is currently considered limited. Genetic associations are often complex, meaning that a single SNP like rs10048146 typically has a very small individual effect on a trait. Many other genetic and environmental factors also play significant roles in determining reproductive timing and bone health. Because the findings are based on population-level statistical associations, they cannot be used to predict an individual's specific health outcomes. Further research is required to confirm these associations across diverse populations and to understand the underlying biological mechanisms.
Population Frequency
The frequency of genetic variants can vary significantly depending on ancestral background. For rs10048146, the minor allele frequency (MAF) is approximately 0.42 in European populations. This means that the variant is relatively common, and a large portion of the population carries at least one copy of the alternative allele. Because this variant is common, it is considered a normal part of human genetic variation rather than a rare mutation. Understanding these frequencies is important for researchers when they design studies to ensure that findings are representative of the broader population. It also highlights that having a particular genotype for this SNP is a standard occurrence for many people, rather than an indicator of a specific health condition.
Interpreting Your Genetic Information
It is important to understand that genetic variants like rs10048146 provide only a small piece of a much larger biological puzzle. You cannot use this information to diagnose a medical condition or predict your future health. Genetic associations are observed at the population level and do not necessarily apply to any single individual. If you have questions about your bone health, reproductive history, or how your genetics might influence your response to medications, the best course of action is to consult with a qualified healthcare provider or a pharmacist. They can help you interpret your health history in the context of your overall well-being and provide guidance based on clinical evidence rather than isolated genetic markers. Always prioritize professional medical advice over information derived from genetic testing reports.
How common is this variant?
The rs10048146 variant is common, with a minor allele frequency of approximately 0.42 in European populations.
Frequently asked questions
Can rs10048146 predict my risk of osteoporosis?
No, this variant cannot predict your risk of osteoporosis. While some research has explored links between ESR1 variants and bone density, these associations are complex and involve many other genetic and lifestyle factors.
Is rs10048146 a mutation that causes disease?
No, rs10048146 is a common genetic variant, not a disease-causing mutation. It is a normal part of human genetic diversity found in a large percentage of the population.
Should I change my medication based on this SNP?
You should never change your medication based on a genetic variant report. Always discuss any concerns about your medication or dosing with your clinician or pharmacist.
Where can I find more information about ESR1?
You can find reliable information about the ESR1 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene functions and their roles in human health.
Sources & further reading
Educational information only, last refreshed 9/25/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10048146?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ESR1
This variant in the estrogen receptor 1 gene is associated with human reproductive behavior and influences estrogen-responsive gene expression.
This variant in the estrogen receptor 1 gene is associated with an increased risk of endometriosis and may influence cognitive aging.
Estrogen receptor 1 variant associated with altered circulating estradiol levels, follicular maturation, and variability in age at natural menopause.
Variant in estrogen receptor 1 associated with variation in female reproductive timing, including age at menarche and natural menopause onset.
Common polymorphism in estrogen receptor alpha (ESR1) affecting target tissue responsiveness to estrogen, recurrent pregnancy loss risk, and bone-reproductive axis interactions.
Estrogen receptor 1 missense and intronic regulatory variation associated with ovarian responsiveness and fertilization rates in assisted reproductive technology.